Re:What other coronaviruses tell us about SARS-CoV-2
by zajio1am on Wednesday April 29, 2020 @08:48PM
(#23026333)
With variolation it was not lower dose, but different (mild) strain (cowpox), which offers cross-immunity to smallpox.
Re:What other coronaviruses tell us about SARS-CoV-2
by InDemoVeritas on Wednesday April 29, 2020 @09:18PM
(#23026501)
It was a controlled infection with Smallpox, by scraping the skin with pus or scab powder from an infected person. Cowpox is what makes the smallpox vaccine.
Re:What other coronaviruses tell us about SARS-CoV-2
by zajio1am on Thursday April 30, 2020 @06:12AM
(#23029278)
You are right.
Re:What other coronaviruses tell us about SARS-CoV-2
by bluGill on Wednesday April 29, 2020 @09:18PM
(#23026500)
If we have a vaccine candidate that is safe, is there any reason not to give it in mass before knowing if it works? The only thing I can come up with is it takes longer to prove safety than effectiveness, but I don't much about this.
Re:What other coronaviruses tell us about SARS-CoV-2
by Majromax on Wednesday April 29, 2020 @09:50PM
(#23026668)
> If we have a vaccine candidate that is safe, is there any reason not to give it in mass before knowing if it works?
Yes. In some cases, the wrong kind of immune response can cause antibody-dependent enhancement (https://en.wikipedia.org/wiki/Antibody-dependent_enhancement), where the immune reaction enhances the severity of the virus.
This is not terribly common, but alas this exact mechanism has been seen in earlier work on SARS.
Re:What other coronaviruses tell us about SARS-CoV-2
by AuryGlenz on Thursday April 30, 2020 @02:11AM
(#23027909)
Also, during the H1N1 scare a vaccine used in Europe caused some people to develop narcolepsy (though perhaps more would have gotten it from the virus itself without a vaccine). It can be hard to determine that something is “safe” quickly.
Re:What other coronaviruses tell us about SARS-CoV-2
by saalweachter on Thursday April 30, 2020 @11:47AM
(#23032137)
SARS-CoV-2 is also at a really awkward point in the fatality curve (with the best estimate of the IFR being around 1%) that you really want to do something, but you also can't really accept a significant chance of that something having a significant side effect.
Making strong guarantees that people will become immune and won't be infected is part of what makes coming up with a vaccine hard. It's apparently pretty easy and quick to come up with vaccine candidates.